Improving Patient Access To Cell And Gene Therapy

Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market.

Precision Medicine Group made a major investment in Precision Advance earlier in 2021 through the acquisition of Project Farma, a bioengineering services firm that supports life sciences researchers. Learn how specializing in planning and implementing complex biomanufacturing strategies has led to the construction of more than a dozen manufacturing facilities.